<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Characteristic findings of different genetic causes of hypercholesterolemia</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Characteristic findings of different genetic causes of hypercholesterolemia</h1>
<div class="graphic"><div class="figure"><div class="ttl">Characteristic findings of different genetic causes of hypercholesterolemia</div><div class="cntnt"><table cellspacing="0"><colgroup span="6" width="16%"></colgroup> <tbody> <tr> <td class="subtitle1" rowspan="2">Disorder</td> <td class="subtitle1" rowspan="2">Estimated prevalence</td> <td class="subtitle1" rowspan="2">Characteristic lipid levels*</td> <td class="subtitle1" colspan="2">Clinical features</td> <td class="subtitle1" rowspan="2">Confirmatory studies</td> </tr> <tr> <td class="subtitle2">In adults</td> <td class="subtitle2">In children</td> </tr> <tr class="divider_bottom"> <td>Heterozygous familial hypercholesterolemia</td> <td>1/200 to 1/300</td> <td> <ul> <li>Elevated TC and LDL-C </li> <li>LDL-C 190 to 450 mg/dL<sup>¶</sup> </li> <li>TG usually normal </li> </ul> </td> <td> <ul> <li>Tendon or tuberous xanthomata </li> <li>Xanthelasmas </li> <li>Corneal arcus </li> <li>Premature CHD </li> </ul> </td> <td> <ul> <li>Subclinical atherosclerosis </li> </ul> </td> <td> <ul> <li>Exclusion of secondary disorders of cholesterol </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Homozygous familial hypercholesterolemia</td> <td>1/1,000,000</td> <td> <ul> <li>Markedly elevated TC and LDL-C </li> <li>Untreated LDL-C &gt;500 mg/dL </li> <li>TG usually normal </li> </ul> </td> <td> <ul> <li>Extensive xanthomata </li> <li>Severe and progressive atherosclerotic cardiovascular disease </li> </ul> </td> <td> <ul> <li>Cutaneous or tendon xanthomata often in the first year of life </li> <li>Premature CHD occurs in childhood if untreated </li> </ul> </td> <td> <ul> <li>Genetic testing for mutations in the LDLR, APOB, and PCSK9 genes </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>FCHL</td> <td>1 to 2%</td> <td> <ul> <li>Phenotypically heterogeneous </li> <li>Elevated TC and/or TG </li> <li>LDL-C/APOB ratio &lt;1.2 </li> </ul> </td> <td> <ul> <li>Xanthelasma </li> <li>Corneal arcus </li> <li>Premature CHD </li> </ul> </td> <td> <ul> <li>Clinical manifestations are typically not seen during childhood </li> </ul> </td> <td> <ul> <li>Similar lipid profile in one first- or two second-degree relatives </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Familial hyperapobetalipoproteinemia</td> <td> <p>&lt;1%</p> Likely a variant of FCHL</td> <td> <ul> <li>APOB &gt;135 mg/dL </li> <li>LDL-C &lt;160 mg/dL </li> <li>LDL-C/APOB ratio &lt;1.2 </li> </ul> </td> <td> <ul> <li>Xanthelasma </li> <li>Premature CHD </li> <li>Obesity </li> </ul> </td> <td> <ul> <li>Clinical manifestations other than obesity are typically not seen during childhood </li> </ul> </td> <td> <ul> <li>Similar lipid profile in at least two first- or second-degree relatives </li> </ul> </td> </tr> <tr class="divider_bottom"> <td>Polygenic hypercholesterolemia</td> <td>&gt;25%</td> <td> <ul> <li>Elevated TC and LDL-C </li> <li>TG usually normal </li> <li>LDL-C 130-250 mg/dL </li> </ul> </td> <td> <ul> <li>Premature CHD </li> <li>Tendon xanthomata are <strong>not</strong> seen </li> </ul> </td> <td> <ul> <li>Clinical manifestations are typically not seen during childhood </li> </ul> </td> <td> </td> </tr> <tr> <td>Familial dysbetalipoproteinemia</td> <td>1/5000</td> <td> <ul> <li>Elevated TC and TG </li> <li>VLDL/TG ratio &gt;0.3 </li> </ul> </td> <td> <ul> <li>Tuboeruptive xanthomata </li> <li>Xanthomata of the palmar creases </li> <li>Premature CHD </li> </ul> </td> <td> <ul> <li>Clinical manifestations are typically not seen during childhood </li> </ul> </td> <td> <ul> <li>APOE isoform analysis </li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">Summary of the clinical features of different lipid disorders.</div><div class="graphic_footnotes">TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglycerides; CHD: coronary heart disease; LDLR: LDL receptor; APOB: apolipoprotein B; PCSK9: proprotein convertase subtilisin kexin 9; FCHL: familial combined hyperlipidemia; VLDL: very low-density lipoprotein; APOE: apolipoprotein E.<br/>* Lipid levels presented in this table represent the typical ranges seen in each disorder, primarily in affected adults. In most of these disorders, there is considerable variability in these values and lipid levels alone generally cannot be used to confirm or exclude the diagnosis.<br/>¶ In pediatric patients, an LDL-C cutoff value of ≥190 mg/dL is generally used to establish a diagnosis of heterozygous FH. However, in patients with a concerning family history (ie, first-degree relatives with hypercholesterolemia and/or early cardiovascular disease), it may be appropriate to use a lower cutoff value (eg, LDL of ≥160 mg/dL).</div><div id="graphicVersion">Graphic 66747 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
